RT
Insider
Rebecca Taub
Pres., R&D, and CMORebecca Taub (Pres., R&D, and CMO) filed 6 Form 4 reports in the trailing twelve months (0 purchases, 6 sales), most often in Madrigal Pharmaceuticals, Inc. (MDGL). The largest single filing was $10.3M of MDGL (18,650 sh across 9 lots, as filed), executed Dec 10 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
6
0 buys · 6 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$21.5M
shares × price, as filed
Last traded
Mar 6
Filed Mar 6
Median ADV $194.4M across their filed names
Open performance→Volume by month
Buys $0
Sells $49.3M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
6 filings
Sector per market data · by filing · past 12 months
Most traded names
MDGLRecent filings
MDGLSALE
Madrigal Pharmaceuticals, Inc.
View filing →
$212K491 sh × $431.94
Exec Mar 6
Filed Mar 6 · 5:30 PM ET MDGLSALE Madrigal Pharmaceuticals, Inc. View filing → $319K
647 sh × $492.42
Exec Jan 26
Filed Jan 26 · 5:30 PM ET MDGLSALE Madrigal Pharmaceuticals, Inc. View filing → $1.1M
2,238 sh × $490.77
Exec Jan 20
Filed Jan 20 · 5:30 PM ET MDGLSALE Madrigal Pharmaceuticals, Inc. View filing → $9.5M
18,171 sh across 23 lots
Exec Jan 9
Filed Jan 13 · 5:30 PM ET MDGLSALE Madrigal Pharmaceuticals, Inc. View filing → $110K
200 sh × $551.24
Exec Jan 9
Filed Jan 13 · 5:30 PM ET MDGLSALE Madrigal Pharmaceuticals, Inc. View filing → $10.3M
18,650 sh across 9 lots
Exec Dec 10 2025
Filed Dec 12 2025 · 5:30 PM ET MDGLSALE Madrigal Pharmaceuticals, Inc. View filing → $16.4M
46,243 sh across 11 lots
Exec Aug 11 2025
Filed Aug 13 2025 · 5:30 PM ET MDGLSALE Madrigal Pharmaceuticals, Inc. View filing → $350K
1,000 sh × $350.01
Exec Jul 18 2025
Filed Jul 22 2025 · 5:30 PM ET More filings →